Menarini was founded in 1886.In 1915 its headquarters were established in Florence.

1

1964 Opening of Laboratorios Menarini in Barcelona, Spain. This was the beginning of Menarini's internationalisation.

1978 Menarini's Research & Development

was set up at the same time patent legislation for pharmaceutical products was introduced.

1992 With the acquisition of Berlin-Chemie, Menarini entered the markets of Central and Eastern Europe.

Milestones

2

2011 Acquisition of Invida Group, with companiescovering 13 Asia-Pacific countries, nownamed Menarini Asia-Pacific.

2003 Inauguration of Menarini Biotech, anitalian biotechnological company thatcan research, develop and manufacturebiotech pharmaceutical products from the laboratory phase up to production for themarket.

2016 Founding of Vaxynethic, a joint venture company dedicated to the research of innovative technologies for vaccines manufacturing.

Acquisition of CellSearch, a U.S.Company developing advanced technologies for cancer diagnostics.

2013 Acquisition of Silicon Biosystems,

a technology start-up for diagnostics from

liquid biopsies.

Source: IQVIA (Retail Market)

3

MENARINI IN THE

35th 13th

Today Menarini is present in more than 100 countries

WORLD COMPANIES EUROPEAN COMPANIES

PLACE

MENARINI IN THE

PLACE

Please Note: 11th among the Big Five (France, Germany, Italy, Spain and UK)

113

794

1,306

1,869

2,627

1964 1978 1992 2000 2004 2008

4

2015

3,326

2016

3,527

2010

3,031

Consolidated turnover(Million euro)

Source: internal data

3,600

2017

Consolidated turnover (Year 2017)

Source: internal data

TURNOVER PER BUSINESS AREA

DOMESTIC/INTERNATIONAL TURNOVER

Other 1%

Pharmaceutical 93%

Diagnostics 6%

Italy 25%

Abroad 75%

5

Menarini in Europe

Sweden: Menarini Diagnostics presence

6

Menarini in the world

The Menarini Group is present with its affiliates, distributors and franchises

in 136 countries worldwide.

7

Asia-Pacific Region – Australia

• 2017 turnover over 350 Million Euro

• More than 3,000 employees

• Direct presence: Singapore (headquarters), China, India, Australia, South Korea, Taiwan, Thailand, the Philippines, Indonesia, Vietnam, New Zealand, Hong Kong and Malaysia.

8

9

*Corporations; 1 Lithuania, Latvia, Estonia2 Honduras, Nicaragua, El Salvador, Guatemala, Panama, Costa Rica

Menarini is leader in many Countries

RANK

Italy* 1Baltic States1 1Uzbekistan*° 1Moldova*° 1

Armenia° 1

Azerbaijan*° 1

Georgia*° 2

Central America 2 4

Bulgaria 4

Kazakhstan 4

Russia 5

Kyrgyzstan*° 5

Ukraine*°° 6

Poland 8

Belarus° 9

Greece 10

Romania 10

Bosnia & H.* 12

Spain 14

Czech* 14

Germany* 15

RANK

Turkey* 15Portugal* 16Croatia* 16Hungary 17

Slovakia* 17

Serbia 17

Luxembourg 19

Belgium* 20

Philippines* 21

Austria* 23

Dominican Rep* 26

Singapore* 26

Slovenia* 26

Ireland* 27

Lebanon* 27

Malaysia* 30

France* 31

Tunisia* 32

Thailand* 33

Switzerland* 36

UK* 37

(Year 2017)

Sources: IQVIA WRP Q4 2017 - ° Local IQVIA Dec 17 - °° PHARMASTAND Dec 17

2016

16,722

2015201020082004200019901964

16,265

12,89012,584

11,170

7,954

3,606

188

10

1994

5,225

Source: internal data

Number of employees

2017

17,029

Employees - % of graduates and technicians

1964 1990 2014

10%

72%91%

11

2017

16 production plantsIn 2017 these plants produced 583 million packs of pharmaceuticals products.

Italy

Pisa, Florence (2 centres),

L'Aquila, Lomagna (Lecco),

Casaletto Lodigiano (Lodi)

Germany Berlin (2 centres), Dresden

Spain Barcelona

Ireland Shannon

Russia Kaluga

Turkey Istanbul

Central America Guatemala City

Indonesia Jakarta

USA Philadelphia (Huntingdon Valley)*

12

* Diagnostic production

Research & Development Centres

13

1978 11 employees in Menarini R&D in Florence

2017 920 employees in Menarini R&D

PISA

FLORENCE

ROMEBARCELONA

BERLIN

BOLOGNA

SINGAPORE